• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FNDC5/鸢尾素在肾细胞癌中的诊断价值。

The Diagnostic Value of FNDC5/Irisin in Renal Cell Cancer.

机构信息

Department Chemistry and Chemical Processing Technology, Ulubey Vocational School, Laboratory Technology Program, Ordu, Turkey.

Department of Medical Biochemistry, Faculty of Medicine, Karadeniz Technical University Trabzon, Turkey.

出版信息

Int Braz J Urol. 2018 Jul-Aug;44(4):734-739. doi: 10.1590/S1677-5538.IBJU.2017.0404.

DOI:10.1590/S1677-5538.IBJU.2017.0404
PMID:29522296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6092672/
Abstract

PURPOSES

The aim of this study was to determine the diagnostic significance of fibronectin type III domain containing protein 5 (FNDC5)/Irisin levels in the sera of patients with renal cell cancer.

MATERIALS AND METHODS

In the study, 48 individuals were evaluated. The patient group included 23 subjects diagnosed with renal tumor, and the control group of 25 healthy individuals. Patients diagnosed with renal tumor received surgical treatment consisting of radical or partial nephrectomy. Blood specimens were collected and serum FNDC5/ Irisin and carcinoembryonic antigen (CEA) levels were determined using enzyme-linked immunosorbent assay (ELISA).

RESULTS

FNDC5/irisin and CEA levels in renal cancer patients were significantly higher compared with the control group (p=0.0001, p=0.009, respectively). Also, FNDC5 levels was more sensitive and specific than CEA levels. The best cut-off points for FNDC5/ irisin were >105pg/mL and CEA were >2.67ng/mL for renal cancer.

CONCLUSIONS

FNDC5/Irisin may be used as a diagnostic biomarker for renal cancer.

摘要

目的

本研究旨在确定血清纤维连接蛋白 III 型结构域蛋白 5(FNDC5)/鸢尾素在肾细胞癌患者中的诊断意义。

材料与方法

本研究共评估了 48 人。患者组包括 23 名经诊断患有肾肿瘤的患者,对照组为 25 名健康个体。经诊断患有肾肿瘤的患者接受了根治性或部分肾切除术的手术治疗。采集血液标本,使用酶联免疫吸附测定(ELISA)法测定血清 FNDC5/鸢尾素和癌胚抗原(CEA)水平。

结果

与对照组相比,肾癌患者的 FNDC5/鸢尾素和 CEA 水平明显升高(p=0.0001,p=0.009)。此外,FNDC5 水平比 CEA 水平更敏感和特异。FNDC5/鸢尾素的最佳截断值>105pg/mL,CEA 的最佳截断值>2.67ng/mL,用于诊断肾癌。

结论

FNDC5/鸢尾素可作为肾细胞癌的诊断生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ca/6092672/2ff34874156a/1677-6119-ibju-44-04-0734-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ca/6092672/9bdad0b42a52/1677-6119-ibju-44-04-0734-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ca/6092672/2ff34874156a/1677-6119-ibju-44-04-0734-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ca/6092672/9bdad0b42a52/1677-6119-ibju-44-04-0734-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ca/6092672/2ff34874156a/1677-6119-ibju-44-04-0734-gf02.jpg

相似文献

1
The Diagnostic Value of FNDC5/Irisin in Renal Cell Cancer.FNDC5/鸢尾素在肾细胞癌中的诊断价值。
Int Braz J Urol. 2018 Jul-Aug;44(4):734-739. doi: 10.1590/S1677-5538.IBJU.2017.0404.
2
SCUBE1: a promising biomarker in renal cell cancer.信号肽CUB和表皮生长因子样结构域蛋白1:肾细胞癌中有前景的生物标志物
Int Braz J Urol. 2017 Jul-Aug;43(4):638-643. doi: 10.1590/S1677-5538.IBJU.2016.0316.
3
Common single nucleotide polymorphisms in the FNDC5 gene are associated with glucose metabolism but do not affect serum irisin levels in Japanese men with low fitness levels.FNDC5 基因常见的单核苷酸多态性与葡萄糖代谢有关,但不影响低健康水平的日本男性的血清鸢尾素水平。
Metabolism. 2014 Apr;63(4):574-83. doi: 10.1016/j.metabol.2014.01.005. Epub 2014 Jan 17.
4
Soluble Ligand of the Immune Checkpoint Receptor (sPD-L1) in Blood Serum of Patients with Renal Cell Carcinoma.肾细胞癌患者血清中免疫检查点受体可溶性配体(sPD-L1)
Bull Exp Biol Med. 2019 Jan;166(3):353-357. doi: 10.1007/s10517-019-04349-8. Epub 2019 Jan 9.
5
Association of metabolic parameters and rs726344 in FNDC5 with serum irisin concentrations.代谢参数与 FNDC5 基因 rs726344 多态性与血清鸢尾素浓度的关系。
Int J Obes (Lond). 2016 Feb;40(2):260-5. doi: 10.1038/ijo.2015.157. Epub 2015 Aug 19.
6
Kidney Injury Molecule-1 (KIM-1) in Blood Plasma of Patients with Clear-Cell Carcinoma.肾透明细胞癌患者血浆中的肾损伤分子-1(KIM-1)
Bull Exp Biol Med. 2019 Jul;167(3):388-392. doi: 10.1007/s10517-019-04533-w. Epub 2019 Jul 26.
7
Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma.血浆胸腺肽-α1 水平作为尿路上皮和肾细胞癌的潜在生物标志物。
Urol Oncol. 2013 Nov;31(8):1806-11. doi: 10.1016/j.urolonc.2012.03.011. Epub 2012 May 19.
8
FNDC5 could be regulated by leptin in adipose tissue.FNDC5 可在脂肪组织中受瘦素调节。
Eur J Clin Invest. 2014 Oct;44(10):918-25. doi: 10.1111/eci.12324. Epub 2014 Sep 3.
9
Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics.乳腺癌患者血清鸢尾素水平较低:与疾病诊断和肿瘤特征的关联
BMC Cancer. 2015 Nov 11;15:898. doi: 10.1186/s12885-015-1898-1.
10
Serum Irisin Predicts Posthepatectomy Complications in Patients with Hepatocellular Carcinoma.血清鸢尾素预测肝细胞癌患者肝切除术后并发症。
Dis Markers. 2019 Dec 28;2019:9850191. doi: 10.1155/2019/9850191. eCollection 2019.

引用本文的文献

1
Irisin's Dual Role in Malignant Tumors and Its Potential as a Biomarker and Therapeutic Target.鸢尾素在恶性肿瘤中的双重作用及其作为生物标志物和治疗靶点的潜力。
Drug Des Devel Ther. 2025 Aug 20;19:7185-7205. doi: 10.2147/DDDT.S532658. eCollection 2025.
2
Irisin Concentrations in Children and Adolescent Cancer Survivors and Their Relation to Metabolic, Bone, and Reproductive Profile: A Pilot Case-Control Study.儿童和青少年癌症幸存者的鸢尾素浓度及其与代谢、骨骼和生殖特征的关系:一项初步病例对照研究。
J Clin Med. 2025 Jul 17;14(14):5098. doi: 10.3390/jcm14145098.
3
FNDC5 and ACOX1 as Biomarkers of Peroxisomal Activity with Contrast Outcomes in Colon Adenocarcinoma.

本文引用的文献

1
SCUBE1: a promising biomarker in renal cell cancer.信号肽CUB和表皮生长因子样结构域蛋白1:肾细胞癌中有前景的生物标志物
Int Braz J Urol. 2017 Jul-Aug;43(4):638-643. doi: 10.1590/S1677-5538.IBJU.2016.0316.
2
Increased FNDC5/Irisin expression in human hepatocellular carcinoma.人类肝细胞癌中FNDC5/鸢尾素表达增加。
Peptides. 2017 Feb;88:62-66. doi: 10.1016/j.peptides.2016.12.014. Epub 2016 Dec 21.
3
Irisin suppresses the migration, proliferation, and invasion of lung cancer cells via inhibition of epithelial-to-mesenchymal transition.
FNDC5和ACOX1作为结肠腺癌中过氧化物酶体活性的生物标志物及对比结果
Biol Proced Online. 2025 Jul 23;27(1):27. doi: 10.1186/s12575-025-00289-y.
4
Role and Functions of Irisin: A Perspective on Recent Developments and Neurodegenerative Diseases.鸢尾素的作用与功能:近期进展及神经退行性疾病视角
Antioxidants (Basel). 2025 May 7;14(5):554. doi: 10.3390/antiox14050554.
5
Identification of a novel PANoptosis-related gene signature for predicting the prognosis in clear cell renal cell carcinoma.鉴定一个新的 PANoptosis 相关基因特征,用于预测透明细胞肾细胞癌的预后。
Medicine (Baltimore). 2024 Sep 27;103(39):e39874. doi: 10.1097/MD.0000000000039874.
6
Effects of Exercise-Induced Changes in Myokine Expression on the Tumor Microenvironment.运动诱导的肌动蛋白表达变化对肿瘤微环境的影响。
Sports Med Int Open. 2024 Jun 19;8:a22831663. doi: 10.1055/a-2283-1663. eCollection 2024.
7
Impact of Nutritional Status of Patients with Head and Neck Squamous Cell Carcinoma on the Expression Profile of Ghrelin, Irisin, and Titin.头颈部鳞状细胞癌患者营养状况对胃饥饿素、鸢尾素和肌联蛋白表达谱的影响。
Cancers (Basel). 2024 Jan 19;16(2):437. doi: 10.3390/cancers16020437.
8
The Modulation of Adipokines, Adipomyokines, and Sleep Disorders on Carcinogenesis.脂肪因子、脂肪肌动蛋白和睡眠障碍对致癌作用的调节
J Clin Med. 2023 Apr 2;12(7):2655. doi: 10.3390/jcm12072655.
9
FNDC5 and AKR1B10 inhibit the proliferation and metastasis of adrenocortical carcinoma cells by regulating AMPK/mTOR pathway.FNDC5和AKR1B10通过调节AMPK/mTOR信号通路抑制肾上腺皮质癌细胞的增殖和转移。
Exp Ther Med. 2023 Feb 13;25(3):136. doi: 10.3892/etm.2023.11835. eCollection 2023 Mar.
10
Expression and prognosis analyses of the fibronectin type-III domain-containing (FNDC) protein family in human cancers: A Review.纤维连接蛋白结构域包含蛋白家族在人类癌症中的表达与预后分析:综述。
Medicine (Baltimore). 2022 Dec 9;101(49):e31854. doi: 10.1097/MD.0000000000031854.
鸢尾素通过抑制上皮-间质转化来抑制肺癌细胞的迁移、增殖和侵袭。
Biochem Biophys Res Commun. 2017 Apr 8;485(3):598-605. doi: 10.1016/j.bbrc.2016.12.084. Epub 2016 Dec 14.
4
Clinical use of cabozantinib in the treatment of advanced kidney cancer: efficacy, safety, and patient selection.卡博替尼在晚期肾癌治疗中的临床应用:疗效、安全性及患者选择
Onco Targets Ther. 2016 Sep 23;9:5825-5837. doi: 10.2147/OTT.S97397. eCollection 2016.
5
New Progress of Epigenetic Biomarkers in Urological Cancer.泌尿系统癌症中表观遗传生物标志物的新进展
Dis Markers. 2016;2016:9864047. doi: 10.1155/2016/9864047. Epub 2016 Aug 9.
6
Irisin immunostaining characteristics of breast and ovarian cancer cells.乳腺癌和卵巢癌细胞的鸢尾素免疫染色特征
Cell Mol Biol (Noisy-le-grand). 2016 Jul 31;62(8):40-4.
7
Investigation of the expression of irisin and some cachectic factors in mice with experimentally induced gastric cancer.探讨实验性诱导胃癌小鼠中鸢尾素和一些恶病质因子的表达。
QJM. 2016 Dec;109(12):785-790. doi: 10.1093/qjmed/hcw074. Epub 2016 Jun 1.
8
Irisin immunohistochemistry in gastrointestinal system cancers.胃肠道系统癌症中的鸢尾素免疫组织化学
Biotech Histochem. 2016;91(4):242-50. doi: 10.3109/10520295.2015.1136988. Epub 2016 Mar 10.
9
Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics.乳腺癌患者血清鸢尾素水平较低:与疾病诊断和肿瘤特征的关联
BMC Cancer. 2015 Nov 11;15:898. doi: 10.1186/s12885-015-1898-1.
10
Regulation of cell proliferation and malignant potential by irisin in endometrial, colon, thyroid and esophageal cancer cell lines.鸢尾素对子宫内膜癌、结肠癌、甲状腺癌和食管癌细胞系中细胞增殖和恶性潜能的调节作用。
Metabolism. 2014 Feb;63(2):188-93. doi: 10.1016/j.metabol.2013.10.005. Epub 2013 Oct 23.